Easton Capital
Easton Capital is a New York-based venture capital firm founded in 1999 that invests $500K-$10M in capital-efficient healthcare and life sciences companies, managing approximately $200 million across multiple funds with a track record of multiple $1B+ exits.
- Company typePrivate
- Founded1999
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Easton Capital does
Easton Capital is a New York-based venture capital firm founded in 1999 that manages approximately $200 million on behalf of institutional investors, with an exclusive sector focus on healthcare and life sciences. The firm pursues a classical venture capital approach, targeting capital-efficient companies that require no more than $10-20 million of additional capital to reach market and become cash flow positive or be acquired, with individual investments ranging from $500,000 to $10 million. Its portfolio is organized across three categories: Healthcare IT, Devices/Diagnostics, and Therapeutics, with notable holdings including Acorda Therapeutics, Cardiovascular Systems, Bluebird bio, Promedior, and TigerText.
The firm operates through multiple fund vehicles including Easton Hunt Capital Partners, Easton Capital Partners, Easton Hunt New York, Easton New Media Fund, and two Special Situations Funds. Easton generates returns through equity appreciation and exits via acquisition or IPO, with a track record of five portfolio companies sold or trading at values greater than $1 billion and more than six investments generating returns in excess of 100x. Revenue mechanics derive from management fees on committed AUM and carried interest on realized gains.
The firm is led by Founder and Managing Partner John H. Friedman (Yale Law; formerly founder of Security Pacific Capital Investors) alongside a senior team including an Executive Partner with 22 years at Johnson & Johnson, four additional Managing Directors with backgrounds spanning Goldman Sachs biotech research, Harvard Law, Princeton/Columbia, and Wharton, plus a General Counsel/MD with 28+ years in venture capital. The team typically leads or co-leads rounds and maintains active board participation, and the firm notes that 40% of CEOs or founders in its latest fund are women.
Easton Capital firmographics
Firmographics- Name
- Easton Capital
- Legal name
- Easton Capital Investment Group
- Website
- https://eastoncapital.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Easton Capital is a New York-based venture capital firm founded in 1999 that invests $500K-$10M in capital-efficient healthcare and life sciences companies, managing approximately $200 million across multiple funds with a track record of multiple $1B+ exits.
- Ownership category
- akta.pro rank
Easton Capital industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Venture Capital Fundraising Placement (FSAEALAC)
Keywords
Where Easton Capital is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Easton Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Venture Capital Fund Management: Easton Capital generates returns through equity investments in healthcare and life sciences companies. Their revenue comes from capital appreciation and returns on investments when portfolio companies are acquired or reach liquidity events. They target investments in companies that will generate significant multiples when successful while minimizing losses on unsuccessful investments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Investment range for portfolio companies |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Easton Capital product offering
Product offeringCore offering
Easton Capital is a New York-based venture capital firm that manages multiple funds investing equity capital in healthcare and life sciences companies. The firm focuses on capital-efficient opportunities typically requiring $10-20 million or less in new capital to reach market and become cash flow positive or be acquired, with individual investment sizes ranging from $500,000 to $10 million. Easton generally leads or co-leads funding rounds and provides hands-on board participation, strategic guidance, and operational support to portfolio companies.
Product overview
Easton Capital is a Venture Capital Fund management firm with a sector focus in healthcare and life sciences, managing approximately $200 million across multiple funds including Easton Hunt Capital Partners, L.P., Easton Capital Partners, L.P., Easton Hunt New York L.P, Easton New Media Fund LP, Easton Special Situations Fund I LLC (ESSF I), and Easton Special Situations Fund II LLC (ESSF II). The firm's investment strategy focuses on capital-efficient healthcare opportunities requiring $10-20 million or less in new capital, typically leading or co-leading investments. The portfolio spans three main categories: Healthcare IT (companies like Kitcheck, Comprehend, Within3, Medikly, PerceptiMed, TigerText), Devices/Diagnostics (companies like Precise Light Surgical, SolX, Electrocore Medical, EMKinetics), and Therapeutics (companies like Promedior, Resolve Bio, Bluebird Bio, Trellis Bioscience). Investment sizes range from $500,000 to $10 million, with a focus on companies that can materially improve healthcare or reduce its cost.
Differentiator
Problem solved
Functional benefit
Products and services
- Easton Hunt Capital Partners, L.P.
Quantifiable outcome
- Five portfolio companies sold or trading at values greater than $1 billion
- +3 more outcomes
Companies that use Easton Capital
Customer profileNamed customers12 records
Segments2 records
Ideal customer profiles2 records
Easton Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Easton Capital partnerships and signals
Strategic signalScale indicators6 records
Recent moves5 records
Expansion highlights4 records
Easton Capital competitors and assessment
Company assessmentDirect peers
- OrbiMed: One of the largest dedicated healthcare venture capital firms globally, investing across therapeutics, medical devices, and diagnostics. Most directly comparable to Easton by sector focus and stage, though at significantly larger AUM scale.
- 5AM Ventures: Healthcare-focused early-stage venture firm investing in therapeutics, devices, and diagnostics with similarly lean team structure and capital-efficient approach. Directly comparable to Easton's investment philosophy and check-size discipline.
- Versant Ventures: Healthcare-dedicated venture firm with practices across therapeutics, medical devices, and healthcare services. Comparable to Easton in cross-subsector healthcare focus and stage orientation, with larger fund vintages.
- Frazier Healthcare Partners: Healthcare-focused investment firm operating both venture and growth-buyout strategies. Comparable to Easton in therapeutic area breadth and active board-participation model.
- Domain Associates: Healthcare-dedicated venture firm investing in therapeutics, medical devices, and diagnostics from early to growth stages. Directly comparable to Easton's sector focus and traditional VC approach.
- Atlas Venture: Early-stage healthcare and technology venture firm with strong emphasis on company formation. Comparable to Easton in stage orientation and cross-subsector healthcare investing.
- ARCH Venture Partners: Healthcare and technology venture firm focused on early-stage breakthrough science investments. Comparable to Easton in healthcare specialization and active board governance, though typically investing in more capital-intensive opportunities.
Broad incumbents
- Novo Holdings (Novo Ventures): Life sciences investor and parent of Novo Nordisk Foundation with healthcare-focused venture arm. Comparable to Easton in therapeutics-focused healthcare investing but operates at vastly larger scale as a strategic/sovereign-backed platform.
- Polaris Partners: Multi-stage venture firm with a dedicated healthcare practice spanning therapeutics, devices, and digital health. Comparable to Easton in cross-subsector healthcare approach though diversified across technology sectors.
- New Enterprise Associates (NEA): One of the largest venture firms with a substantial healthcare practice alongside technology investments. Comparable to Easton in cross-subsector healthcare exposure but vastly larger and more diversified.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Easton Capital social profiles
Digital presenceEaston Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Easton Capital leadership team
Management profileNumber of profiles
Profiles9 records
Easton Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Easton Capital M&A and investment
M&A and investmentM&A
Investments78 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Easton Capital
What does Easton Capital do?
Easton Capital is a New York-based venture capital firm that manages multiple funds investing equity capital in healthcare and life sciences companies. The firm focuses on capital-efficient opportunities typically requiring $10-20 million or less in new capital to reach market and become cash flow positive or be acquired, with individual investment sizes ranging from $500,000 to $10 million. Easton generally leads or co-leads funding rounds and provides hands-on board participation, strategic guidance, and operational support to portfolio companies.
Is Easton Capital a public or private company?
Easton Capital is a private company. It is classified as management employee owned and is currently operating.
When was Easton Capital founded?
Easton Capital was founded in 1999. It employs 1 to 10 people.
Where is Easton Capital based?
Easton Capital is headquartered in New York, United States, in the North America region.
How does Easton Capital make money?
One revenue line is on record: venture Capital Fund Management.
Who are Easton Capital's main competitors?
Direct peers on record are OrbiMed, 5AM Ventures, Versant Ventures, Frazier Healthcare Partners, Domain Associates, Atlas Venture and ARCH Venture Partners. Broad incumbents are Novo Holdings (Novo Ventures), Polaris Partners and New Enterprise Associates (NEA).
Does Easton Capital have an API?
No public API is recorded for Easton Capital.
What industry is Easton Capital in?
Easton Capital's product category is Venture Capital. Its primary akta.pro industry code is FSAEALAC, Venture Capital Fundraising Placement. Its NAICS code is 523940 and its SIC code is 6282.